Evidence map›Paper›PMID 26200910›Full record

ArticlePLoS pathogens2015

Analysis of the SUMO2 Proteome during HSV-1 Infection.

Elizabeth Sloan, Michael H Tatham, Marine Groslambert, Mandy Glass, Anne Orr, Ronald T Hay, Roger D Everett

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. SUMOylation and Viral Infections of the Brain.Pathogens (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. SUMO: a novel target for anti-coronavirus therapy.Pathogens and global health · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elizabeth SloanMRC-University of Glasgow Centre for Virus Research, The Sir Michael Stoker Building, University of Glasgow Garscube Campus, Glasgow, Scotland, United Kingdom.
Michael H TathamCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Sir James Black Centre, Dundee, United Kingdom.
Marine GroslambertMRC-University of Glasgow Centre for Virus Research, The Sir Michael Stoker Building, University of Glasgow Garscube Campus, Glasgow, Scotland, United Kingdom.
Mandy GlassMRC-University of Glasgow Centre for Virus Research, The Sir Michael Stoker Building, University of Glasgow Garscube Campus, Glasgow, Scotland, United Kingdom.
Anne OrrMRC-University of Glasgow Centre for Virus Research, The Sir Michael Stoker Building, University of Glasgow Garscube Campus, Glasgow, Scotland, United Kingdom.
Ronald T HayCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Sir James Black Centre, Dundee, United Kingdom.
Roger D EverettMRC-University of Glasgow Centre for Virus Research, The Sir Michael Stoker Building, University of Glasgow Garscube Campus, Glasgow, Scotland, United Kingdom.
MRC University of Glasgow Centre for Virus Research · GBUniversity of Dundee · GB

Funding

Cancer Research UK 13067Cancer Research UK C434/A13067Medical Research Council MC_U130169966Medical Research Council MC_UU_12014/4MRF_ MRF-149-0001-RG-GLASSWellcome Trust 097945Wellcome Trust 098391Wellcome Trust 098391/Z/12/Z
6 · The paper itself

Abstract

Covalent linkage to members of the small ubiquitin-like (SUMO) family of proteins is an important mechanism by which the functions of many cellular proteins are regulated. Sumoylation has roles in the control of protein stability, activity and localization, and is involved in the regulation of transcription, gene expression, chromatin structure, nuclear transport and RNA metabolism. Sumoylation is also linked, both positively and negatively, with the replication of many different viruses both in terms of modification of viral proteins and modulation of sumoylated cellular proteins that influence the efficiency of infection. One prominent example of the latter is the widespread reduction in the levels of cellular sumoylated species induced by herpes simplex virus type 1 (HSV-1) ubiquitin ligase ICP0. This activity correlates with relief from intrinsic immunity antiviral defence mechanisms. Previous work has shown that ICP0 is selective in substrate choice, with some sumoylated proteins such the promyelocytic leukemia protein PML being extremely sensitive, while RanGAP is completely resistant. Here we present a comprehensive proteomic analysis of changes in the cellular SUMO2 proteome during HSV-1 infection. Amongst the 877 potentially sumoylated species detected, we identified 124 whose abundance was decreased by a factor of 3 or more by the virus, several of which were validated by western blot and expression analysis. We found many previously undescribed substrates of ICP0 whose degradation occurs by a range of mechanisms, influenced or not by sumoylation and/or the SUMO2 interaction motif within ICP0. Many of these proteins are known or are predicted to be involved in the regulation of transcription, chromatin assembly or modification. These results present novel insights into mechanisms and host cell proteins that might influence the efficiency of HSV-1 infection.

Indexed as

Herpesvirus 1, HumanCell LineGene Expression Regulation, ViralHost-Pathogen InteractionsHumansProteomeProteomicsSmall Ubiquitin-Related Modifier ProteinsTranscription FactorsTumor Suppressor ProteinsViral ProteinsProteomeSmall Ubiquitin-Related Modifier ProteinsSUMO2 protein, humanTranscription FactorsTumor Suppressor ProteinsViral Proteins

Identifiers

PMID26200910
PMCPMC4511656
OpenAlexW1750656282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.